Literature DB >> 19037828

Nephrogenic diabetes insipidus with dilatation of bilateral renal pelvis, ureter and bladder.

Xiao-Dong Jin1, Zhao-Dian Chen, Song-Liang Cai, Shan-Wen Chen.   

Abstract

OBJECTIVE: Nephrogenic diabetes insipidus (NDI) with dilatation of upper urinary tract and bladder is rarely reported. This study evaluated the urological manifestations and treatment results of this rare condition.
MATERIAL AND METHODS: According to a fluid deprivation test, seven men and two women were diagnosed as NDI, and underwent ultrasonography, magnetic resonance urography, cystography, and urodynamic and laboratory examination. A micturition diary and symptoms were recorded before and during treatment. All patients were given hydrochlorothiazide and followed up with ultrasonography, the postvoiding residual volume (PVR), urinalysis and kidney function tests.
RESULTS: All patients presented with polydipsia and polyuria with severe dilatation of upper urinary tract and bladder. Urodynamics showed that the mean values of the bladder capacity, bladder pressure at the end of filling, maximum flow rate (Q(max)), detrusor pressure and PVR were 1056.3 ml, 40.5 cmH(2)O, 30.8 ml/s, 51.3 cmH(2)O, 436.3 ml, respectively. The total urine volume in all patients decreased by more than 50% after administration of hydrochlorothiazide, which improved the symptoms and hydronephrosis in seven cases. The symptoms of other two cases were relieved after treatment with an electric transurethral incision of the bladder neck and a cystostomy.
CONCLUSIONS: NDI should be considered in patients with dilatation of the urinary tract and polyuria. Higher bladder pressure at the end of filling may contribute to the dilatation of urinary tract. Normal detrusor contractility with large PVR is a unique manifestation of this condition. Controlling the urine volume and reducing the PVR are of key importance in the treatment of this condition.

Entities:  

Mesh:

Year:  2009        PMID: 19037828     DOI: 10.1080/00365590802580208

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  7 in total

1.  Canagliflozin retards age-related lesions in heart, kidney, liver, and adrenal gland in genetically heterogenous male mice.

Authors:  Jessica M Snyder; Kerriann M Casey; Andrzej Galecki; David E Harrison; Hashan Jayarathne; Navasuja Kumar; Francesca Macchiarini; Nadia Rosenthal; Marianna Sadagurski; Adam B Salmon; Randy Strong; Richard A Miller; Warren Ladiges
Journal:  Geroscience       Date:  2022-08-16       Impact factor: 7.581

2.  Hnf4a Is Required for the Development of Cdh6-Expressing Progenitors into Proximal Tubules in the Mouse Kidney.

Authors:  Sierra S Marable; Eunah Chung; Joo-Seop Park
Journal:  J Am Soc Nephrol       Date:  2020-08-06       Impact factor: 10.121

3.  Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients.

Authors:  Niek F Casteleijn; A Lianne Messchendorp; Kyong T Bae; Eiji Higashihara; Peter Kappert; Vicente Torres; Esther Meijer; Anna M Leliveld
Journal:  Clin Exp Nephrol       Date:  2016-06-23       Impact factor: 2.801

4.  Upper urinary dilatation and treatment of 26 patients with diabetes insipidus: A single-center retrospective study.

Authors:  Xuesheng Wang; Xiaoqian Ying; Fan Zhang; Xing Li; Guoqing Chen; Zhonghan Zhou; Limin Liao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

5.  Nonobstructive hydronephrosis due to social polydipsia: a case report.

Authors:  Natallia Maroz; Uladzimir Maroz; Saima Iqbal; Ravi Aiyer; Ganesh Kambhampati; A Ahsan Ejaz
Journal:  J Med Case Rep       Date:  2012-11-06

6.  Congenital Nephrogenic Diabetes Insipidus Presented With Bilateral Hydronephrosis and Urinary Infection: A Case Report.

Authors:  Kewen Zheng; Yi Xie; Hanzhong Li
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

7.  Nephrogenic diabetes insipidus induced by ureter obstruction due to benign prostatic hyperplasia: A case report.

Authors:  Hanyu Lou; Yimin Shen; Yi Xu; Wei Zhang; Yuezhong Ren
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.